Nordhealth AS (OSL:NORDH)
Norway · Delayed Price · Currency is NOK 36.00
-1.00 (-2.70%)
Aug 5, 2025, 4:25 PM CET
bluebird bio Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2020 |
Operating Revenue | 42.09 | 40.2 | 33.09 | 28.22 | 18.46 | 12.68 | Upgrade |
Other Revenue | 5.92 | 5.48 | 3.74 | 2.83 | 1.84 | - | Upgrade |
| 48.01 | 45.68 | 36.83 | 31.05 | 20.3 | 12.68 | Upgrade | |
Revenue Growth (YoY) | 25.35% | 24.03% | 18.60% | 52.96% | 60.04% | 66.02% | Upgrade |
Cost of Revenue | 31.43 | 30.01 | 27.66 | 27.04 | 13.64 | 7.31 | Upgrade |
Gross Profit | 16.58 | 15.67 | 9.16 | 4.01 | 6.67 | 5.38 | Upgrade |
Selling, General & Admin | 2.38 | 2.38 | 2.59 | 2.76 | 1.12 | - | Upgrade |
Other Operating Expenses | 10.94 | 10.2 | 7.82 | 7.23 | 5.77 | 1.93 | Upgrade |
Operating Expenses | 24.18 | 23.39 | 20.55 | 18.69 | 11.12 | 3.44 | Upgrade |
Operating Income | -7.6 | -7.73 | -11.39 | -14.68 | -4.46 | 1.94 | Upgrade |
Interest Expense | -0.04 | -0.04 | -0.01 | -0.02 | -0.04 | -0.25 | Upgrade |
Interest & Investment Income | 0.22 | 0.22 | 0.15 | 0.11 | - | 0.28 | Upgrade |
Currency Exchange Gain (Loss) | 0.12 | 0.12 | -0.26 | 0.46 | -0.15 | - | Upgrade |
Other Non Operating Income (Expenses) | 0.33 | 0.78 | 0.7 | 0 | - | - | Upgrade |
EBT Excluding Unusual Items | -6.97 | -6.64 | -10.81 | -14.13 | -4.65 | 1.96 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.04 | Upgrade |
Pretax Income | -6.97 | -6.64 | -10.81 | -14.13 | -4.65 | 2 | Upgrade |
Income Tax Expense | 1.06 | 1.04 | 0.33 | 0.14 | 0.09 | 0.07 | Upgrade |
Net Income | -8.03 | -7.67 | -11.13 | -14.26 | -4.73 | 1.93 | Upgrade |
Net Income to Common | -8.03 | -7.67 | -11.13 | -14.26 | -4.73 | 1.93 | Upgrade |
Shares Outstanding (Basic) | 79 | 79 | - | 80 | 80 | 80 | Upgrade |
Shares Outstanding (Diluted) | 79 | 79 | - | 80 | 80 | 80 | Upgrade |
Shares Change (YoY) | - | - | - | 0.24% | - | - | Upgrade |
EPS (Basic) | -0.10 | -0.10 | - | -0.18 | -0.06 | 0.02 | Upgrade |
EPS (Diluted) | -0.10 | -0.10 | - | -0.18 | -0.06 | 0.02 | Upgrade |
Free Cash Flow | -1.1 | -3.17 | -10.95 | -13.1 | 2.19 | - | Upgrade |
Free Cash Flow Per Share | -0.01 | -0.04 | - | -0.16 | 0.03 | - | Upgrade |
Gross Margin | 34.54% | 34.30% | 24.88% | 12.93% | 32.83% | 42.40% | Upgrade |
Operating Margin | -15.82% | -16.91% | -30.92% | -47.27% | -21.96% | 15.26% | Upgrade |
Profit Margin | -16.72% | -16.80% | -30.23% | -45.94% | -23.30% | 15.20% | Upgrade |
Free Cash Flow Margin | -2.29% | -6.94% | -29.72% | -42.20% | 10.79% | - | Upgrade |
EBITDA | -0.69 | -0.87 | -1.25 | -5.98 | -0.22 | 3.45 | Upgrade |
EBITDA Margin | -1.44% | -1.91% | -3.39% | -19.24% | -1.09% | 27.19% | Upgrade |
D&A For EBITDA | 6.91 | 6.86 | 10.14 | 8.7 | 4.24 | 1.51 | Upgrade |
EBIT | -7.6 | -7.73 | -11.39 | -14.68 | -4.46 | 1.94 | Upgrade |
EBIT Margin | -15.82% | -16.91% | -30.92% | -47.27% | -21.96% | 15.26% | Upgrade |
Effective Tax Rate | - | - | - | - | - | 3.63% | Upgrade |
Revenue as Reported | 47.97 | 45.68 | 36.83 | 31.05 | 20.3 | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.